The #1 personalized Peptide/GLP care app.
Try Now →
- Tweets 748
- Following 12
- Followers 1,136
- Likes 758
Pinned Tweet
REGEN product update is live
we are building the most transparent peptide health startup out there. here is what we changed:
+ Easier Add Peptide Flow that can smart map & dosing history for any compound
+ Peptide Vendor Research/Breakdown Tab
+ Updated Community Reports on all compounds
+ Compound Update (44 → 67)
+ Complete Rewrite of Peptide Library (highest quality facts, studies, sources etc.)
+ Added a Peptide Encyclopedia on the Web (regenhealth[.]app)
+ Smoother App Perfomance
+ Improved Design and UX
go update your apps and check us out on the web!
1
1
11
4,710
There's a recovery peptide that started as a fragment of a protein in human stomach juice. It still has no FDA-approved indication, and FDA & HHS just said they won't go after pharmacies compounding it.
Here's the weird origin story: (1/12)
1
1
159
Takeaway: a stomach-juice fragment became a gray-market recovery staple, then a compounding policy fight. The origin is wild. The human evidence is still catching up. (12/12)
1
18
Sources:
HHS interim compounding policy (Federal Register Oct 30, 2026)
FDA PCAC July 2026 recommendations on peptide bulks
Regen BPC-157 grade:
regenhealth.app/library/reco…
20
Bofanglutide vs Ozempic 🧪
- Semaglutide is S-tier on Regen; Bofanglutide is the once-monthly GLP-1 just starting Phase 3 maintenance
- Semaglutide has years of human data and FDA approval as Ozempic and Wegovy
- Bofanglutide is built for a monthly shot cadence instead of weekly
- Track record still favors Semaglutide; monthly dosing is the only edge Bofanglutide is pitching so far
1
1
276
